SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-024973
Filing Date
2024-02-16
Accepted
2024-02-16 16:53:32
Documents
20
Period of Report
2024-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246547d1_8k.htm   iXBRL 8-K 36951
2 EXHIBIT 10.2 tm246547d1_ex10-2.htm EX-10.2 57685
3 EXHIBIT 10.3 tm246547d1_ex10-3.htm EX-10.3 138074
4 EXHIBIT 10.4 tm246547d1_ex10-4.htm EX-10.4 15209
5 EXHIBIT 10.5 tm246547d1_ex10-5.htm EX-10.5 5491
9 GRAPHIC tm246547d1_ex10-5img001.jpg GRAPHIC 6455
10 GRAPHIC tm246547d1_ex10-5img002.jpg GRAPHIC 1979
  Complete submission text file 0001104659-24-024973.txt   491961

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20240212.xsd EX-101.SCH 3030
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20240212_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20240212_pre.xml EX-101.PRE 22369
21 EXTRACTED XBRL INSTANCE DOCUMENT tm246547d1_8k_htm.xml XML 3459
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36081 | Film No.: 24649171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)